Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Ennist

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 13, 2026
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage populationDanielle Beaulieu, Kelly Smith, Campbell Ross, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2015
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Neta Zach, David L Ennist, Albert A Taylor, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 15, 2022
Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALSShiran Salomon-Zimri, Avital Pushett, Niva Russek-Blum, et al.
Annals of Clinical and Translational Neurology|December 20, 2018
Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosisKatharine Nicholson, James Chan, Eric A Macklin, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 13, 2026
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage populationDanielle Beaulieu, Kelly Smith, Campbell Ross, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2015
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Neta Zach, David L Ennist, Albert A Taylor, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 15, 2022
Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALSShiran Salomon-Zimri, Avital Pushett, Niva Russek-Blum, et al.
Annals of Clinical and Translational Neurology|December 20, 2018
Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosisKatharine Nicholson, James Chan, Eric A Macklin, et al.
Pageof 2